Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency × Pluvicto × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 10 Kidney Neoplasms 2 Carcinoma, Renal Cell 2 Renal Insufficiency 1 Prostatic Neoplasms, Castration-Resistant 1

Interventions

Cyclophosphamide 2 gallium 68 PSMA-11 1 Whole-Body Irradiation 1 Pluvicto 1 Eplerenone 1 Dexamethasone 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06004661 2026-03-06

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Novartis

Phase 2 Recruiting

Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡